TC Biopharm (Holdings) Plc (TCBP) Analyst Estimates Annual - Discounting Cash Flows
TCBP
TC Biopharm (Holdings) Plc
TCBP (NASDAQ)
Period Ending: 2025
12-31
2024
12-31
2023
12-31
2022
12-31
Number of Analysts 0 0 0 1
Estimated Revenue
Low 0 0 0 1.95
Average 0 0 0 1.95
High 0 0 0 1.95
Estimated EBITDA
Low 0 0 0 -1.17
Average 0 0 0 -1.17
High 0 0 0 -1.17
Estimated EBIT
Low 0 0 0 -1.17
Average 0 0 0 -1.17
High 0 0 0 -1.17
Estimated Net Income
Low 0 -0.001 -38.53 -0.696
Average 0 -0.001 -38.53 -0.696
High 0 -0.001 -38.53 -0.696
Estimated SGA Expenses
Low 0 0 0 2.67
Average 0 0 0 2.67
High 0 0 0 2.67
Estimated EPS
Low 0 -0.002 -62.36 -22.52
Average 0 -0.002 -62.36 -22.52
High 0 -0.002 -62.36 -22.52
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program